A Xarelto patient is fighting back against the reversal of a $28 million verdict against drug maker Johnson & Johnson (subsidiaries Bayer and Janssen), which she initially won for an alleged failure to warn against the heightened risk of internal bleeding. The verdict in Hartman et al v. Janssen Pharmaceuticals…
The first lawsuit against Bayer AG and Janssen involving the drug Xarelto has started in a state court. Most products liability cases involving dangerous or defective drugs are filed in federal district courts. These cases can however, be filed in state courts across the county so long as jurisdiction is…
Xarelto is a member of a class of blood thinners known as new oral anticoagulants. It was primarily developed by German pharmaceutical giant Bayer AG as a drug that could compete with Warfarin (Coumadin) that has been the gold standard of blood thinners for many years. Bayer partnered with a…
Xaretlto and its competitors were manufactured and marketed as anticoagulant medications that were a one-dose-fits-all solution. This defectively designed medication with insufficient warnings turned out be a very dangerous option for many patients and turned out not to be that perfect one-dose solution it was heralded to be for those…
Xarelto is a member of a class of drugs known as New Oral Anticoagulants (NOACs). This class of drugs also includes several competitors to Xaretlo, including Eliquis, Pradaxa, and Savaysa, which is the newest class member. These medications are approved by the U.S. Food and Drug Administration (FDA), to treat…
There is no question that millions of Americans are in need of potentially life-saving medications to prevent strokes from occurring. In fact, as discussed in a recent Bio Pharma Dive article, strokes are up in the U.S. The conventional treatment for strokes for decades was Warfarin (Coumadin), which is a…
Drug companies are big multinational corporations for the most part, and as such report their profits and losses to Wall Street each quarter. That means these firms are very concerned about making money for their shareholders and their executives. There is no question many medicines they make save a lot of lives.…
According to a recent news article from the Madison St. Clair Record, a plaintiff has just filed a products liability lawsuit against the makers of Xarelto, Bayer Pharmaceuticals and Janssen Research and Development. Janssen Research and Development was formerly known as Johnson and Johnson Pharmaceuticals Research and is still a…
According to a recent news article from the Cook County Record, a woman has just filed a lawsuit against Bayer and Johnson & Johnson/Janssen Pharmaceuticals, who are the makers and U.S. marketing partners of the New Oral Anticoagulant (NOAC) Xarelto. This lawsuit alleges that, after taking Xarelto, she suffered serious…
Last year, the United States Food and Drug Administration (FDA) became aware that a device used to monitor a patient’s blood in Xarelto clinical trials had problems. Now it has been reported by British Medical Journal, and via FiercePharma, that the two major drug companies (Janssen/Johnson & Johnson and Bayer…